STD Awareness: Confronting Sky-High STD Rates

For the past five years, Americans have been breaking records left and right — a good thing when we’re talking about athletic feats or scientific breakthroughs, but not so great when we’re shattering records for catching sexually transmitted diseases (STDs). Chlamydia, gonorrhea, and syphilis are all on the upswing, with a combined 2.3 million cases in 2017 — and those are just the cases that were reported. Since most people with these infections don’t know they have them, the real number is thought to be much higher. The United States has the dubious honor of boasting the highest STD rates of all industrialized countries — though rates are also climbing in England and Western Europe.

The good news is that these three STDs are preventable and curable. Sexually active people can dramatically reduce their risk by using condoms and dental dams, or by being in mutually monogamous relationships in which partners test negative for these infections. And, because many STDs don’t show symptoms, it’s important for them to receive regular STD screening to ensure infections are caught and cured before they can do any damage.

But there’s also bad news. First, while the symptoms of these infections can be awful, they compel you to seek prompt treatment — making these awful symptoms a good thing, in a weird way. Unfortunately, most people with these infections don’t have symptoms, allowing the bacteria that cause them to spread silently from person to person. If not caught, chlamydia and gonorrhea can lead to chronic pain and fertility problems, and syphilis can lead to organ damage and even death. These infections can also increase HIV risk and be passed to a baby during childbirth. Continue reading

STD Awareness: UK Announces “Worst-Ever” Case of Gonorrhea

In late March, the BBC reported a story that was widely repeated in headlines across the world: “Man has ‘world’s worst’ super-gonorrhoea.”

The article told the story of a British man whose symptoms started in early 2018, about a month after he had picked up the bug during a visit to Southeast Asia. Once back home, his doctors were unable to cure it with the standard combination of azithromycin and ceftriaxone — “the first time the infection cannot be cured with first choice antibiotics,” the author wrote.


In most of the world, we don’t have a good picture of antibiotic resistance in gonorrhea.


Actually, a similar case of multidrug-resistant gonorrhea had been documented in the United Kingdom in late 2014, as noted in the New England Journal of Medicine. It was the first verified case to fail to be cured by the azithromycin/ceftriaxone combo — the infection didn’t go away until after the patient was given a double dose of both antibiotics, but by then it had been 112 days and the infection could have cleared on its own. By July 2017, the World Health Organization (WHO) had noted that there had been multiple documented cases of gonorrhea that were “untreatable by all known antibiotics.”

What was different about the man in the BBC story was that his case of ceftriaxone-resistant gonorrhea had a higher level of azithromycin resistance than those that came before. While it may not have truly been the first case of multidrug-resistant gonorrhea that couldn’t be treated with the standard dual therapy of azithromycin and ceftriaxone, it was the “most serious.” Continue reading

STD Awareness: Transgender Men and Cervical Health

Healthy cervical cells as seen under a microscope. Image: National Cancer Institute

Just one month ago, headlines screamed that the Centers for Disease Control and Prevention (CDC) received a list of “banned words” from the Trump administration. One of those words was transgender, raising the alarm that the current president might be eyeing policies that would further marginalize the trans population and harm their health. (Other forbidden words include fetus, evidence-based, and vulnerable.) Some have argued it wasn’t Trump policy per se, but self-censoring on the part of the CDC to protect their budgets from being slashed by legislators hostile to transgender rights, abortion rights, science, people of color, and poor people.

In any case, refusing to use words like transgender can have grave consequences for trans health. If the CDC can’t reference the trans population when requesting money for services and studies, they will be hobbled in their ability to serve that population’s needs.


Recommendations for cervical cancer screening are the same for anyone with a cervix, whether trans or cisgender.


January is Cervical Health Awareness Month. Anyone who has a cervix can develop cervical cancer — including transgender men who have not had their cervixes surgically removed. In observance of the month, and in defiance of directions to avoid the word transgender, today we’ll discuss the importance of cervical health in trans men — and why taxpayer-funded entities like the CDC and the National Institutes of Health must be able to study and serve this population.

Transgender men (or trans men for short) are individuals born with female reproductive organs, but who identify as male. Likewise, cisgender women were born with female reproductive organs and identify as female. Both trans men and cisgender women were born with cervixes, and wherever a cervix exists, the possibility of cervical cancer exists. Continue reading

For the Safety of Students: Five Questions for Mary Koss

Mary P. Koss, Ph.D.

With close to 300 peer-reviewed publications and a number of academic awards to her name, it’s hard to believe that University of Arizona Regents’ Professor Mary P. Koss once had to fight her way into the doctoral program in psychology at the University of Minnesota. Her test scores put her head and shoulders above other applicants, but it took a tense meeting with the department head — in which she let a bit of profanity slip out — to finally get accepted into their graduate school. Clinical psychology was a very male-dominated field in the early 1980s, when she was starting her career, and that was all too clear when a colleague shared his idea for a study that would explore male undergraduates’ attitudes toward rape — by having models pose in varying sizes of padded bras and be rated for their desirability and culpability if raped.


The term date rape was first used in the news media 35 years ago this month.


From that conversation, though, came the seed of an idea that would soon set Dr. Koss apart from her peers. At that time, Dr. Koss was at Kent State in Ohio, still years before she joined the University of Arizona. She made a name for herself studying campus sexual assault by developing a survey that revolutionized efforts to gauge respondents’ experiences of sexual aggression and victimization, revealing a higher prevalence than previously thought. Her initial study was publicized 35 years ago this month, in Ms. Magazine’s September 1982 issue, in an article that also marked the first time a national news publication used the term date rape. Both Dr. Koss’ research and the introduction of that term to the national conversation were game-changers in many ways.

At the time the article was published, most rape-prevention programs on college campuses were relatively new and narrowly focused on the danger posed by strangers — the assailants waiting in alleyways, rather than the familiar faces in classrooms or dorms. Dr. Koss’ research, as well as the stories writer Karen Barrett reported from Stanford University and the University of Connecticut for the Ms. article, revealed that many cases of rape, especially those committed by the victims’ peers and acquaintances, were often ignored, denied, or misunderstood as something other than rape. The concept of date rape helped many people recognize rape — their own or others’ — that had been perpetrated by people known to the victims.

Greater awareness and understanding of the problem of campus sexual assault soon followed, but the 35 years since then have seen both progress and setbacks. In fact, as the anniversary of that historic Ms. article approached, news began coming from the Department of Education that Secretary of Education Betsy DeVos vowed to revisit Obama-era policies that addressed campus sexual assault. A series of information-gathering meetings included a group that, according to the Southern Poverty Law Center, seeks “to roll back services for victims of domestic abuse and penalties for their tormentors.” Continue reading

STD Awareness: Is Gonorrhea Becoming “Impossible” to Treat?

Image: National Institute of Allergy and Infectious Disease

Health authorities have been worried about it for a long time now, and we’ve been following it on our blog since 2012. The boogeyman? Antibiotic-resistant gonorrhea, a strain of the sexually transmitted bacteria that is becoming more and more difficult to treat. Higher doses of the drug will be needed to cure stubborn cases of gonorrhea — until the doses can no longer be increased. Then, untreatable gonorrhea could be a reality.


“Little now stands between us and untreatable gonorrhea.”


The World Health Organization (WHO), in a press release last month, finally used the word “impossible” when describing treatment of antibiotic-resistant gonorrhea, referring to documented cases of gonorrhea that were “untreatable by all known antibiotics.” Worse, these cases are thought to be the proverbial “tip of the iceberg,” as there aren’t good data on antibiotic-resistant gonorrhea in many developing countries, where gonorrhea is more prevalent and epidemics could be spreading under the radar. Adding to this problem is the fact that gonorrhea rates are climbing worldwide, which is thought to be due to a number of factors, including the decline in condom use, the frequent absence of symptoms, inadequate treatment, and increasing urbanization and travel.

What will happen if gonorrhea can’t be cured? Your infection could clear up on its own, after a lengthy battle with your immune system, but we don’t know a lot about how long this could take (weeks? months? never?). Unfortunately, despite your immune system’s best efforts, gonorrhea doesn’t go out without a fight. Gonorrhea can lead to pelvic inflammatory disease, which can cause tissue damage to the reproductive organs resulting in infertility, ectopic pregnancy, and chronic pain. It can also cause scarring that blocks sperm’s movement out of the testes, resulting in epididymitis, which is associated with infertility, chronic scrotal pain, and testicular shrinkage. Furthermore, gonorrhea increases risk for HIV transmission and can be passed to a baby during childbirth. The CDC estimates that, in the United States alone, untreatable gonorrhea could cause 75,000 cases of pelvic inflammatory disease, 15,000 cases of epididymitis, and 222 extra HIV infections over a 10-year period. Worldwide, where gonorrhea and HIV disproportionately affect developing countries, these problems could get even more out of control. Continue reading

STD Awareness: Gonorrhea’s Latest Dubious Honor

Wanted: Scientists who can develop novel antibiotics

A few years ago, the Centers for Disease Control and Prevention (CDC) put out a “greatest hits” list of antibiotic-resistant pathogens. More recently, in late February, the World Health Organization (WHO) followed suit with a dirty-dozen list of 12 “superbugs,” which was composed mostly of potentially fatal microbes that are becoming increasingly impervious to the drugs that once easily killed them. These are the bacteria WHO believes represent the greatest microbial threat to human health, and the list was compiled in the hopes of providing direction — and motivation — to pharmaceutical researchers who are desperately needed to develop new antibiotics.


Investing in antibiotic development now will save lives later.


A quick primer on antibiotic resistance: Antibiotics kill living organisms called bacteria, but like all living organisms, bacteria can evolve. Just as giraffes evolve longer and longer necks that allow them to eat more and more leaves, so too do bacteria evolve resistance to antibiotics. For example, a resistant bacterium can evolve the ability to spit out the drug before it has a chance to kill it, or it can evolve structural changes to its cell wall that make it impossible for the drug to attach to it.

One superbug, classified as an “urgent threat” by the CDC and a “high priority” by WHO, stands out from the pack. Unlike the other bacteria in these lists, an untreated infection with this bug isn’t thought to be deadly — but it still wreaks enough havoc to merit special attention from such esteemed bodies as the CDC and WHO. That bug is Neisseria gonorrhoeae, and you have one guess what disease it causes. (If you said gonorrhea, you guessed right.) Continue reading

STD Awareness: Fully Antibiotic-Resistant Gonorrhea Is on the Horizon

shot-in-armWe’ve been anticipating its arrival for years now, but earlier this fall, the Centers for Disease Control and Prevention (CDC) finally made an announcement: Cases of gonorrhea resistant to the last drugs we use to cure it are emerging.

Over the years, gonorrhea has evolved resistance to every drug we’ve thrown at it — sulfonamides, penicillins, tetracyclines, macrolides, fluoroquinolones, and narrow-spectrum cephalosporins. The last line of defense we have is a one-two punch of a pair of antibiotics: azithromycin and ceftriaxone. By using two drugs, we can delay the inevitable evolution of antibiotic resistance by attacking the bacteria in two vulnerable locations, rather than just one, making it more difficult for the bug to mount a defense and pass on its superior survival skills to subsequent generations.


Prevention is paramount: Stop the spread of antibiotic resistance by practicing safer sex!


Unfortunately, we could only stave off the inevitable for so long. At their conference in September, the CDC announced a cluster of gonorrhea infections that are highly resistant to azithromycin, and that fall prey only to high doses of ceftriaxone. As gonorrhea’s tolerance to ceftriaxone increases, the infection will get more and more difficult to cure.

This cluster of drug-resistant cases was identified in Honolulu in April and May of this year, with five infections showing “dramatic” resistance to azithromycin, as well as reduced vulnerability to ceftriaxone. The good news is that these cases were cured with higher-than-usual doses of antibiotics, but the bad news is that dosages can only climb so high before a drug is no longer considered to be an effective treatment. Continue reading